|

Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial

RECRUITINGN/ASponsored by Steno Diabetes Center Copenhagen
Actively Recruiting
PhaseN/A
SponsorSteno Diabetes Center Copenhagen
Started2026-03-20
Est. completion2027-12-31
Eligibility
Age18 Years – 74 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07485075

Summary

This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).

Eligibility

Age: 18 Years – 74 YearsHealthy volunteers accepted
Inclusion Criteria:

* Type 2 diabetes (ICD-10 DE11.x)
* Age 18-74 years
* BMI \< 35 kg/m²
* eGFR 30-59 ml/min and UACR \> 30 mg/g
* Stable medication for ≥3 months
* Ability to read and understand Danish

Exclusion Criteria:

* Type 1 diabetes or other diabetes types
* Current vegan diet
* Active cancer
* Short bowel syndrome or celiac disease
* Use of sodium chloride tablets
* No access to digital platform (intervention group only)

Conditions3

DiabetesDiabetes Type 2Kidney Disease

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.